On December 21, 2024, the Taiwan Regenerative Medicine Delegation, led by Dr. Chiang Hsi-Jen, Chairman of the National Federation of Dental Associations of the Republic of China and National Policy Advisor, visited the Odawara Hakone Medical Checkup Clinic in Japan. This visit aimed to strengthen Taiwan-Japan collaboration in regenerative medicine and foster deeper research into cutting-edge biomedical applications. The delegation included prominent members such as YC Biotech CEO Lin Yu-Ming and the innovative EG Biomed team from Taipei Medical University, showcasing Taiwan’s commitment to advancing precision medicine technologies.
JY Biomedical: Pioneering Regenerative Medicine
At the forefront of this collaboration is JY Biomedical, whose advanced UC-MSC (umbilical cord mesenchymal stem cell) and UC-MSC-Exosome (exosomes derived from UC-MSCs) products represent a cornerstone of Taiwan's efforts in regenerative medicine. As the exclusive agent of these innovative products, YC Biotech is working closely with JY Biomedical to explore their application in personalized healthcare and regenerative therapies. These bioproducts hold immense potential for enhancing tissue repair, reducing inflammation, and addressing unmet medical needs, offering patients new hope for improved health outcomes.
Dr. Chiang emphasized the importance of uniting Taiwan's top biomedical teams, including JY Biomedical, to deepen cross-border research and development in stem cell and exosome technologies. By leveraging JY Biomedical’s expertise, the delegation is not only promoting Taiwan’s regenerative medicine capabilities but also paving the way for innovative healthcare solutions through international cooperation.
Advancing Precision Medicine at Odawara Hakone Medical Checkup Clinic
The Odawara Hakone Medical Checkup Clinic, located conveniently near Odawara Station, is renowned for its world-class health screening and precision medicine services. The clinic specializes in early detection and personalized management of diseases such as gastric, colorectal, and breast cancers. With a strong focus on women’s health, the clinic provides tailored screening days and specialized services to ensure comfort, privacy, and accuracy.
The delegation explored the clinic’s advanced regenerative medicine services, which align with JY Biomedical’s mission to integrate stem cell and exosome technologies into practical healthcare applications. The clinic’s recent success in precision and regenerative medicine underscores the value of its collaboration with Taiwanese biomedical innovators like JY Biomedical and its partners.
Taiwan-Japan Collaboration in Early Cancer Detection
YC Biotech CEO Lin Yu-Ming highlighted the significance of early detection and prevention in precision medicine. By integrating advanced methylation cancer testing technology developed by EG Biomed and collaborating with JY Biomedical’s expertise in stem cell and exosome therapies, the delegation aims to revolutionize cancer diagnosis and treatment. These efforts focus on creating high-accuracy testing systems for detecting early-stage cancers, reducing the risk of disease progression, and improving patient outcomes.
Building a Global Biomedical Ecosystem
The partnership between JY Biomedical, YC Biotech, and Japanese medical institutions represents a significant step toward establishing a global biomedical ecosystem. This collaboration combines Taiwan’s strengths in biotechnology with Japan’s advanced medical infrastructure, driving innovation in precision medicine and regenerative therapies. By incorporating JY Biomedical’s groundbreaking UC-MSC and exosome products, this partnership aims to deliver transformative healthcare solutions.
A Holistic Healing Experience
Beyond medical advancements, the Taiwan Regenerative Medicine Delegation experienced the cultural and scenic beauty of Odawara Castle. This unique approach to healthcare combines state-of-the-art medical services with cultural enrichment, offering patients a holistic healing journey for both mind and body.
JY Biomedical’s leadership in regenerative medicine and its collaboration with international partners are shaping the future of precision healthcare. By integrating cutting-edge biotechnologies with cultural sensitivity, Taiwan and Japan are creating a new paradigm for global health innovation.
Comments